Literature DB >> 27878525

Genetics of Frontotemporal Dementia.

Diana A Olszewska1, Roisin Lonergan1, Emer M Fallon1, Tim Lynch2.   

Abstract

Frontotemporal dementia (FTD) is the second most common cause of dementia following Alzheimer's disease (AD). Between 20 and 50% of cases are familial. Mutations in MAPT, GRN and C9orf72 are found in 60% of familial FTD cases. C9orf72 mutations are the most common and account for 25%. Rarer mutations (<5%) occur in other genes such as VPC, CHMP2B, TARDP, FUS, ITM2B, TBK1 and TBP. The diagnosis is often challenging due to symptom overlap with AD and other conditions. We review the genetics, clinical presentations, neuroimaging, neuropathology, animal studies and therapeutic trials in FTD. We describe clinical scenarios including the original family with the tau stem loop mutation (+14) and also the recently discovered 'missing tau' mutation +15 that 'closed the loop' in 2015.

Entities:  

Keywords:  +15; DDPAC; FTDP-17; Frontotemporal dementia; Genetics

Mesh:

Substances:

Year:  2016        PMID: 27878525     DOI: 10.1007/s11910-016-0707-9

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  108 in total

1.  Pallidopontonigral degeneration: a deceptive familial tauopathy.

Authors:  Seán O'Dowd; Brian Murray; Kinley Roberts; Gemma Cummins; Brian Magennis; Timothy Lynch
Journal:  Mov Disord       Date:  2012-06       Impact factor: 10.338

2.  A decamer duplication in the 3' region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred.

Authors:  R Vidal; T Revesz; A Rostagno; E Kim; J L Holton; T Bek; M Bojsen-Møller; H Braendgaard; G Plant; J Ghiso; B Frangione
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

3.  Association of an extended haplotype in the tau gene with progressive supranuclear palsy.

Authors:  M Baker; I Litvan; H Houlden; J Adamson; D Dickson; J Perez-Tur; J Hardy; T Lynch; E Bigio; M Hutton
Journal:  Hum Mol Genet       Date:  1999-04       Impact factor: 6.150

4.  Tau haplotype frequency in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Alun Hughes; David Mann; Stuart Pickering-Brown
Journal:  Exp Neurol       Date:  2003-05       Impact factor: 5.330

Review 5.  Intracellular and extracellular microtubule associated protein tau as a therapeutic target in Alzheimer disease and other tauopathies.

Authors:  Jesús Avila; Noemí Pallas; Marta Bolós; C Laura Sayas; Felix Hernandez
Journal:  Expert Opin Ther Targets       Date:  2016-02-16       Impact factor: 6.902

6.  Structure-Activity Relationship Study of Heterocyclic Phenylethenyl and Pyridinylethenyl Derivatives as Tau-Imaging Agents That Selectively Detect Neurofibrillary Tangles in Alzheimer's Disease Brains.

Authors:  Kenji Matsumura; Masahiro Ono; Ayane Kitada; Hiroyuki Watanabe; Masashi Yoshimura; Shimpei Iikuni; Hiroyuki Kimura; Yoko Okamoto; Masafumi Ihara; Hideo Saji
Journal:  J Med Chem       Date:  2015-09-01       Impact factor: 7.446

7.  Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-parkinsonism-amyotrophy complex.

Authors:  T Lynch; M Sano; K S Marder; K L Bell; N L Foster; R F Defendini; A A Sima; C Keohane; T G Nygaard; S Fahn
Journal:  Neurology       Date:  1994-10       Impact factor: 9.910

Review 8.  C9orf72 expansions in frontotemporal dementia and amyotrophic lateral sclerosis.

Authors:  Jonathan D Rohrer; Adrian M Isaacs; Sarah Mizielinska; Simon Mead; Tammaryn Lashley; Selina Wray; Katie Sidle; Pietro Fratta; Richard W Orrell; John Hardy; Janice Holton; Tamas Revesz; Martin N Rossor; Jason D Warren
Journal:  Lancet Neurol       Date:  2015-01-29       Impact factor: 44.182

9.  HDAC2 negatively regulates memory formation and synaptic plasticity.

Authors:  Ji-Song Guan; Stephen J Haggarty; Emanuela Giacometti; Jan-Hermen Dannenberg; Nadine Joseph; Jun Gao; Thomas J F Nieland; Ying Zhou; Xinyu Wang; Ralph Mazitschek; James E Bradner; Ronald A DePinho; Rudolf Jaenisch; Li-Huei Tsai
Journal:  Nature       Date:  2009-05-07       Impact factor: 49.962

10.  Assessing THK523 selectivity for tau deposits in Alzheimer's disease and non-Alzheimer's disease tauopathies.

Authors:  Michelle T Fodero-Tavoletti; Shozo Furumoto; Leanne Taylor; Catriona A McLean; Rachel S Mulligan; Ian Birchall; Ryuichi Harada; Colin L Masters; Kazuhiko Yanai; Yukitsuka Kudo; Christopher C Rowe; Nobuyuki Okamura; Victor L Villemagne
Journal:  Alzheimers Res Ther       Date:  2014-02-26       Impact factor: 6.982

View more
  37 in total

Review 1.  Preserving Lysosomal Function in the Aging Brain: Insights from Neurodegeneration.

Authors:  Wesley Peng; Georgia Minakaki; Maria Nguyen; Dimitri Krainc
Journal:  Neurotherapeutics       Date:  2019-07       Impact factor: 7.620

Review 2.  Alzheimer's Disease and Frontotemporal Dementia: The Current State of Genetics and Genetic Testing Since the Advent of Next-Generation Sequencing.

Authors:  Jill S Goldman; Vivianna M Van Deerlin
Journal:  Mol Diagn Ther       Date:  2018-10       Impact factor: 4.074

Review 3.  Genetic testing for neurodegenerative diseases: Ethical and health communication challenges.

Authors:  J Scott Roberts; Anne K Patterson; Wendy R Uhlmann
Journal:  Neurobiol Dis       Date:  2020-04-14       Impact factor: 5.996

4.  SRSF1-dependent inhibition of C9ORF72-repeat RNA nuclear export: genome-wide mechanisms for neuroprotection in amyotrophic lateral sclerosis.

Authors:  Lydia M Castelli; Luisa Cutillo; Cleide Dos Santos Souza; Alvaro Sanchez-Martinez; Ilaria Granata; Ya-Hui Lin; Monika A Myszczynska; Paul R Heath; Matthew R Livesey; Ke Ning; Mimoun Azzouz; Pamela J Shaw; Mario R Guarracino; Alexander J Whitworth; Laura Ferraiuolo; Marta Milo; Guillaume M Hautbergue
Journal:  Mol Neurodegener       Date:  2021-08-10       Impact factor: 14.195

Review 5.  Nuclear pore complexes - a doorway to neural injury in neurodegeneration.

Authors:  Alyssa N Coyne; Jeffrey D Rothstein
Journal:  Nat Rev Neurol       Date:  2022-04-29       Impact factor: 42.937

Review 6.  Modelling amyotrophic lateral sclerosis in rodents.

Authors:  Tiffany W Todd; Leonard Petrucelli
Journal:  Nat Rev Neurosci       Date:  2022-03-08       Impact factor: 34.870

Review 7.  Protein misassembly and aggregation as potential convergence points for non-genetic causes of chronic mental illness.

Authors:  Nicholas J Bradshaw; Carsten Korth
Journal:  Mol Psychiatry       Date:  2018-08-08       Impact factor: 15.992

8.  Rare variants in the neuronal ceroid lipofuscinosis gene MFSD8 are candidate risk factors for frontotemporal dementia.

Authors:  Ethan G Geier; Mathieu Bourdenx; Nadia J Storm; J Nicholas Cochran; Daniel W Sirkis; Ji-Hye Hwang; Luke W Bonham; Eliana Marisa Ramos; Antonio Diaz; Victoria Van Berlo; Deepika Dokuru; Alissa L Nana; Anna Karydas; Maureen E Balestra; Yadong Huang; Silvia P Russo; Salvatore Spina; Lea T Grinberg; William W Seeley; Richard M Myers; Bruce L Miller; Giovanni Coppola; Suzee E Lee; Ana Maria Cuervo; Jennifer S Yokoyama
Journal:  Acta Neuropathol       Date:  2018-10-31       Impact factor: 17.088

9.  Gene Expression and RNA Splicing Imputation Identifies Novel Candidate Genes Associated with Osteoporosis.

Authors:  Yong Liu; Hui Shen; Jonathan Greenbaum; Anqi Liu; Kuan-Jui Su; Li-Shu Zhang; Lei Zhang; Qing Tian; Hong-Gang Hu; Jin-Sheng He; Hong-Wen Deng
Journal:  J Clin Endocrinol Metab       Date:  2020-12-01       Impact factor: 5.958

Review 10.  Combating deleterious phase transitions in neurodegenerative disease.

Authors:  April L Darling; James Shorter
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2021-02-05       Impact factor: 4.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.